GMP-Compliant Isolation and Large-Scale Expansion of Bone Marrow-Derived MSC

被引:146
作者
Fekete, Natalie [1 ,2 ]
Rojewski, Markus T. [1 ,2 ]
Fuerst, Daniel [2 ]
Kreja, Ludwika [3 ]
Ignatius, Anita [3 ]
Dausend, Julia [1 ,2 ]
Schrezenmeier, Hubert [1 ,2 ]
机构
[1] Univ Ulm Klinikum, Inst Transfus Med, Ulm, Germany
[2] Inst Klin Transfus Med & Immungenet, Ulm, Germany
[3] Inst Unfallchirurg Forsch & Biomech, Ulm, Germany
关键词
MESENCHYMAL STEM-CELLS; STROMAL CELLS; PHENOTYPIC CHARACTERIZATION; DONOR VARIATION; HUMAN PLACENTA; DIFFERENTIATION; BLOOD;
D O I
10.1371/journal.pone.0043255
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
070301 [无机化学]; 070403 [天体物理学]; 070507 [自然资源与国土空间规划学]; 090105 [作物生产系统与生态工程];
摘要
Background: Mesenchymal stromal cells (MSC) have gained importance in tissue repair, tissue engineering and in immunosupressive therapy during the last years. Due to the limited availability of MSC in the bone marrow, ex vivo amplification prior to clinical application is requisite to obtain therapeutic applicable cell doses. Translation of preclinical into clinical-grade large-scale MSC expansion necessitates precise definition and standardization of all procedural parameters including cell seeding density, culture medium and cultivation devices. While xenogeneic additives such as fetal calf serum are still widely used for cell culture, its use in the clinical context is associated with many risks, such as prion and viral transmission or adverse immunological reactions against xenogeneic components. Methods and Findings: We established animal-free expansion protocols using platelet lysate as medium supplement and thereby could confirm its safety and feasibility for large-scale MSC isolation and expansion. Five different GMP-compliant standardized protocols designed for the safe, reliable, efficient and economical isolation and expansion of MSC was performed and MSC obtained were analyzed for differentiation capacity by qPCR and histochemistry. Expression of standard MSC markers as defined by the International Society for Cellular Therapy as well as expression of additional MSC markers and of various chemokine and cytokine receptors was analysed by flow cytometry. Changes of metabolic markers and cytokines in the medium were addressed using the LUMINEX platform. Conclusions: The five different systems for isolation and expansion of MSC described in this study are all suitable to produce at least 100 millions of MSC, which is commonly regarded as a single clinical dose. Final products are equal according to the minimal criteria for MSC defined by the ISCT. We showed that chemokine and integrin receptors analyzed had the same expression pattern, suggesting that MSC from either of the systems show equal characteristics of homing and adhesion.
引用
收藏
页数:14
相关论文
共 31 条
[1]
Consensus Guidance for Banking and Supply of Human Embryonic Stem Cell Lines for Research Purposes [J].
Andrews, Peter W. ;
Arias-Diaz, Javard ;
Auerbach, Jonathan ;
Alvarez, Manuel ;
Ahrlund-Richter, Lars ;
Baker, Duncan ;
Benvenisty, Nissim ;
Ben-Josef, Dalit ;
Blin, Guillaume ;
Borghese, Lodovica ;
Borstlap, Joeri ;
Bruce, Kevin ;
Bruestle, Oliver ;
Buckle, Robin ;
Camby, Carine ;
Choo, Andre ;
Chen, Wannhsin ;
Collins, Daniel ;
Colman, Alan ;
Crombie, Catriona ;
Crook, Jeremy ;
Cypess, Ray ;
De Sousa, Paul ;
Dhawan, Jyotsna ;
Douay, Luc ;
Dvorak, Petr ;
Dyke, Timothy ;
Eriksson, Lena ;
Firpo, Meri ;
Fitzgerald, Claire ;
Glover, Clive ;
Gokhale, Paul ;
Greene, Michele ;
Ha, Hye-Yeong ;
Hampl, Ales ;
Healy, Lyn ;
Hei, Derek ;
Holm, Frida ;
Hovatta, Outi ;
Hunt, Charles ;
Hwang, Shiaw-Min ;
Inamdar, Maneesha ;
Isasi, Rosario ;
Itskovitz-Eldor, Joseph ;
Jessie, Nancy ;
Kim, Dong-Wook ;
Kirzner, Rosemarie ;
Kiatpongsan, Sorapop ;
Knowles, Barbara ;
Kuo, Hung-Chih .
STEM CELL REVIEWS AND REPORTS, 2009, 5 (04) :301-314
[2]
[Anonymous], 2007, Official Journal of the European Union, V10-12-2007, P121
[3]
Influence of platelet-rich plasma (PRP) on osteogenic differentiation of rat bone marrow stromal cells.: An in vitro study [J].
Arpornmaeklong, P ;
Kochel, M ;
Depprich, R ;
Kübler, NR ;
Würzler, KK .
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2004, 33 (01) :60-70
[4]
Prospective isolation and characterization of mesenchymal stem cells from human placenta using a frizzled-9-specific monoclonal antibody [J].
Battula, Venkata Lokesh ;
Treml, Sabrina ;
Abele, Harald ;
Buehring, Hans-Joerg .
DIFFERENTIATION, 2008, 76 (04) :326-336
[5]
Ex vivo expansion of mesenchymal stromal cells [J].
Bernardo, Maria Ester ;
Cometa, Angela Maria ;
Pagliara, Daria ;
Vinti, Luciana ;
Rossi, Francesca ;
Cristantielli, Rosaria ;
Palumbo, Giuseppe ;
Locatelli, Franco .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2011, 24 (01) :73-81
[6]
Human Alternatives to Fetal Bovine Serum for the Expansion of Mesenchymal Stromal Cells from Bone Marrow [J].
Bieback, Karen ;
Hecker, Andrea ;
Kocaoemer, Asli ;
Lannert, Heinrich ;
Schallmoser, Katharina ;
Strunk, Dirk ;
Klueter, Harald .
STEM CELLS, 2009, 27 (09) :2331-2341
[7]
Phenotypic Characterization of Distinct Human Bone Marrow-Derived MSC Subsets [J].
Buehring, Hans-Joerg ;
Treml, Sabrina ;
Cerabona, Flavianna ;
de Zwart, Peter ;
Kanz, Lothar ;
Sobiesiak, Malgorzata .
HEMATOPOIETIC STEM CELLS VII, 2009, 1176 :124-134
[8]
Bundesarztekammer, 2010, RICHTL GEW BLUT BLUT
[9]
CAPLAN AI, 1994, CLIN PLAST SURG, V21, P429
[10]
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement [J].
Dominici, M. ;
Le Blanc, K. ;
Mueller, I. ;
Slaper-Cortenbach, I. ;
Marini, F. C. ;
Krause, D. S. ;
Deans, R. J. ;
Keating, A. ;
Prockop, D. J. ;
Horwitz, E. M. .
CYTOTHERAPY, 2006, 8 (04) :315-317